跳至主要内容
临床试验/NCT06439953
NCT06439953招募中不适用

Impact of Prophylactic Use of Irrisept Irrigation System for Spinal Instrumentation

Rhode Island Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Occurrence of surgical site infection

研究概览

简要总结

Various spine surgeons perform wound irrigation using saline mixed with vancomycin, relying on mechanical debridement of non-viable tissue, physical disruption of biofilm, and bacteriostatic effect against gram positive flora. When used as a powder, topical application of vancomycin has demonstrated increased risk of symptomatic seroma formation, which is an adverse outcome that often requires bedside or intra-operative aspiration. Broad-spectrum antiseptic agents, such as Irrisept, offer bacteriocidal properties to eliminate hardware inoculation, thereby minimizing the risk of deep space infection, while obviating the risk of seroma development.

详细描述

Spinal instrumentation remains the standard of care in the treatment of various traumatic, oncologic, and degenerative spinal pathologies, often requiring the implantation of hardware to stabilize the bony column. In the setting of an aging patient population and expanding indications for instrumentation in younger patients, the number of spinal operations performed has risen substantially within the past decade. Although these procedures have proven to enhance patient quality of life, spinal instrumentation is not without post-operative complication, most notable of which are surgical site infection, seroma formation, and wound breakdown. Such complications can result in notable negative sequelae. Recurrent seroma may compress underlying neurologic structures or increase pressure along the incision, thereby precipitating wound dehiscence and inoculation of the surgical site with pathogenic organisms. Deep space infections often result in prolonged hospitalization, long-term suppressive antibiotic therapy, hardware removal, and permanent disability, which increases cost burden at the patient and hospital level. As such, preventative strategies to reduce the rate of complications following spinal instrumentation remain paramount. Within recent years, attention has turned to various irrigation methods to terminally sterilize prosthetic devices and wound beds, thereby minimizing bacterial colonization and biofilm formation that would otherwise predispose infection.

Irrisept (Irrimax Corporation, Gainesville, Florida) is a solution comprised of 0.05% chlorhexidine gluconate in 99.95% sterile water administered through a proprietary, low-pressure lavage mechanism that has demonstrated efficacy as a bacteriocidal agent in orthopedic hip and knee arthroplasty procedures. Whereas other antiseptic irrigation solutions, such as vancomycin-saline lavage, are routinely used to prevent surgical site infection, relative inertness against gram negative organisms and potential predisposition toward seroma formation render them non-ideal for use in spine surgery. Despite the utility of dilute chlorhexidine gluconate as a prophylactic irrigant, there exist gaps in knowledge with regard to the efficacy of Irrisept to prevent post-operative complications following spinal instrumentation. The central hypothesis of this proposal is that prophylactic use of Irrisept irrigation will result in fewer surgical site infections, clinically significant seromas, and gram negative or atypical infections when compared to standard of care irrigation (vancomycin-saline solution with or without topical vancomycin powder).

Proposed is a prospective, randomized controlled trial comparing rates of post-operative complications following use of Irrisept irrigation alone versus vancomycin-saline lavage with or without topical vancomycin powder (standard of care) in patients aged 18 years or older who undergo posterior cervical, thoracic, lumbar, and/or sacral spinal instrumentation for various indications (deformity, malignancy, degenerative pathology, and trauma) at Rhode Island Hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age: 18+ years old
  • •Indications: deformity, oncologic, degenerative, trauma
  • •Standard layer-by-layer closure
  • •Locoregional flap-based closure

排除标准

  • •Acute/chronic open wounds (spine or non-spine)
  • •On-going non-spinal infection within 30 days of index operation
  • •Concurrent antibiotic use (for spine or non-spine infections)
  • •History of prior spinal infection
  • •Allergy to vancomycin or chlorhexidine
  • •Suspicion for osteomyelitis
  • •Other surgery within 90 days post-operatively fromm index
  • •Concurrent enrollment in other trial

研究组 & 干预措施

Irrisept Irrigation

Experimental

Patients scheduled to undergo spinal instrumentation will receive intra-operative Irrisept irrigation.

干预措施: Chlorhexidine gluconate solution (Device)

Vancomycin-saline Irrigation

Active Comparator

Patients scheduled to undergo spinal instrumentation will receive intra-operative irrigation using vancomycin-saline irrigation.

干预措施: Vancomycin (Drug)

结局指标

主要结局

Occurrence of surgical site infection

时间窗: 90 days post-operatively

Development of infection after index spinal instrumentation

次要结局

  • Mortality(12 months post-operatively)
  • Duration of index hospitalization(12 months post-operatively)
  • Presence of atypical micro-organisms on wound fluid laboratory culture(12 months post-operatively)
  • Occurrence of 30-day readmission(30 days post-operatively)
  • Cost of spine surgery care from surgery to 12-month post-operative follow up(12 months post-operatively)
  • Occurrence of wound dehiscence(12 months post-operatively)
  • Time to closed suction drain removal(12 months post-operatively)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验